Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 591

1.

Predicting 10-Year Risk of End-Organ Complications of Type 2 Diabetes With and Without Metabolic Surgery: A Machine Learning Approach.

Aminian A, Zajichek A, Arterburn DE, Wolski KE, Brethauer SA, Schauer PR, Nissen SE, Kattan MW.

Diabetes Care. 2020 Feb 6. pii: dc192057. doi: 10.2337/dc19-2057. [Epub ahead of print]

PMID:
32029638
2.

Predicting Personalized Risk of Mood Recurrences in Youths and Young Adults With Bipolar Spectrum Disorder.

Birmaher B, Merranko JA, Gill MK, Hafeman D, Goldstein T, Goldstein B, Hower H, Strober M, Axelson D, Ryan N, Yen S, Diler R, Iyengar S, Kattan MW, Weinstock L, Keller M.

J Am Acad Child Adolesc Psychiatry. 2020 Jan 21. pii: S0890-8567(20)30021-6. doi: 10.1016/j.jaac.2019.12.005. [Epub ahead of print]

PMID:
31978620
4.

Risk prediction for severe hypoglycemia in a type 2 diabetes population with previous non-severe hypoglycemia.

Misra-Hebert AD, Ji X, Pantalone KM, Hu B, Dey T, Milinovich A, Bauman JM, Zimmerman RS, Kattan MW.

J Diabetes Complications. 2020 Jan;34(1):107490. doi: 10.1016/j.jdiacomp.2019.107490. Epub 2019 Nov 12.

PMID:
31757766
5.

Multi-cohort modeling strategies for scalable globally accessible prostate cancer risk tools.

Tolksdorf J, Kattan MW, Boorjian SA, Freedland SJ, Saba K, Poyet C, Guerrios L, De Hoedt A, Liss MA, Leach RJ, Hernandez J, Vertosick E, Vickers AJ, Ankerst DP.

BMC Med Res Methodol. 2019 Oct 15;19(1):191. doi: 10.1186/s12874-019-0839-0.

6.

Risk Factors for Loss to Follow-up in 3202 Patients at 2 Years After Anterior Cruciate Ligament Reconstruction: Implications for Identifying Health Disparities in the MOON Prospective Cohort Study.

Ramkumar PN, Tariq MB; MOON Knee Group, Amendola A, Andrish JT, Brophy RH, Dunn WR, Flanigan DC, Huston LJ, Jones MH, Kaeding CC, Kattan MW, Marx RG, Matava MJ, McCarty EC, Parker RD, Vidal AF, Wolcott ML, Wolf BR, Wright RW, Spindler KP.

Am J Sports Med. 2019 Nov;47(13):3173-3180. doi: 10.1177/0363546519876925. Epub 2019 Oct 7.

PMID:
31589465
7.

Development of Nomograms to Predict the Recovery of Erectile Function Following Radical Prostatectomy.

Mulhall JP, Kattan MW, Bennett NE, Stasi J, Nascimento B, Eastham J, Guillonneau B, Scardino PT.

J Sex Med. 2019 Nov;16(11):1796-1802. doi: 10.1016/j.jsxm.2019.08.003. Epub 2019 Sep 11.

PMID:
31521569
8.

Association of Metabolic Surgery With Major Adverse Cardiovascular Outcomes in Patients With Type 2 Diabetes and Obesity.

Aminian A, Zajichek A, Arterburn DE, Wolski KE, Brethauer SA, Schauer PR, Kattan MW, Nissen SE.

JAMA. 2019 Sep 2. doi: 10.1001/jama.2019.14231. [Epub ahead of print]

PMID:
31475297
9.

In-hospital red blood cell distribution width change in patients with heart failure.

Xanthopoulos A, Papamichalis M, Zajichek A, Milinovich A, Kattan MW, Skoularigis J, Starling RC, Triposkiadis F.

Eur J Heart Fail. 2019 Dec;21(12):1659-1661. doi: 10.1002/ejhf.1546. Epub 2019 Jul 4. No abstract available.

PMID:
31273906
10.

THE BENEFIT OF SHORT-TERM WEIGHT LOSS WITH ANTI-OBESITY MEDICATIONS IN REAL-WORLD CLINICAL PRACTICE.

Shibuya K, Ali KF, Ji X, Milinoivh A, Bauman J, Kattan MW, Pantalone KM, Burguera B.

Endocr Pract. 2019 Oct;25(10):1022-1028. doi: 10.4158/EP-2019-0081. Epub 2019 Jun 26.

PMID:
31241358
11.

The Main Predictors of Length of Stay After Total Knee Arthroplasty: Patient-Related or Procedure-Related Risk Factors.

Piuzzi NS, Strnad GJ, Sakr Esa WA, Barsoum WK, Bloomfield MR, Brooks PJ, Higuera-Rueda CA, Joyce MJ, Kattan MW, Klika AA, Krebs V, Mesko NW, Mont MA, Murray TG, Muschler GF, Nickodem RJ, Patel PD, Schaffer JL, Spindler KP, Stearns KL, Suarez JC, Zajichek A, Molloy RM; Cleveland Clinic Orthopaedic Arthroplasty Group.

J Bone Joint Surg Am. 2019 Jun 19;101(12):1093-1101. doi: 10.2106/JBJS.18.00758.

PMID:
31220026
12.

Development and validation of a model to predict outcomes of colon cancer surveillance.

Rose J, Homa L, Kong CY, Cooper GS, Kattan MW, Ermlich BO, Meyers JP, Primrose JN, Pugh SA, Shinkins B, Kim U, Meropol NJ.

Cancer Causes Control. 2019 Jul;30(7):767-778. doi: 10.1007/s10552-019-01187-x. Epub 2019 May 25.

PMID:
31129907
13.

The index of prediction accuracy: an intuitive measure useful for evaluating risk prediction models.

Kattan MW, Gerds TA.

Diagn Progn Res. 2018 May 4;2:7. doi: 10.1186/s41512-018-0029-2. eCollection 2018.

14.

Predicting seizure freedom after epilepsy surgery, a challenge in clinical practice.

Gracia CG, Chagin K, Kattan MW, Ji X, Kattan MG, Crotty L, Najm I, Gonzalez-Martinez J, Bingaman W, Jehi L.

Epilepsy Behav. 2019 Jun;95:124-130. doi: 10.1016/j.yebeh.2019.03.047. Epub 2019 Apr 28.

PMID:
31035104
15.

A Tool for Shared Decision Making on Referral for Prostate Biopsy in the Primary Care Setting: Integrating Risks of Cancer with Life Expectancy.

Verbeek JFM, Nieboer D, Parker C, Kattan MW, Steyerberg EW, Roobol MJ.

J Pers Med. 2019 Apr 22;9(2). pii: E19. doi: 10.3390/jpm9020019.

16.

Testosterone replacement therapy and the risk of adverse cardiovascular outcomes and mortality.

Pantalone KM, George J, Ji X, Kattan MW, Milinovich A, Bauman JM, Burguera B, Zimmerman RS, Misra-Hebert AD.

Basic Clin Androl. 2019 Mar 29;29:5. doi: 10.1186/s12610-019-0085-7. eCollection 2019.

17.

Decision models for distinguishing between clinically insignificant and significant tumors in prostate cancer biopsies: an application of Bayes' Theorem to reduce costs and improve outcomes.

Swersey AJ, Colberg J, Evans R, Kattan MW, Ledolter J, Parker R.

Health Care Manag Sci. 2019 Mar 18. doi: 10.1007/s10729-019-09480-6. [Epub ahead of print]

PMID:
30880374
18.

Implementing a Scientifically Valid, Cost-Effective, and Scalable Data Collection System at Point of Care: The Cleveland Clinic OME Cohort.

Cleveland O, Piuzzi NS, Strnad G, Brooks P, Hettrich CM, Higuera-Rueda C, Iannotti J, Kattan MW, Molloy R, Lynch TS, Milinovich A, Ricchetti ET, Rosneck J, Schickendantz M, Spindler KP; OME Cleveland Clinic Orthopaedics.

J Bone Joint Surg Am. 2019 Mar 6;101(5):458-464. doi: 10.2106/JBJS.18.00767.

PMID:
30845040
19.

Intensification patterns and the probability of HbA1c goal attainment in Type 2 diabetes mellitus: real-world evidence for the concept of 'intensification inertia'.

Pantalone KM, Misra-Hebert AD, Hobbs TM, Ji X, Kong SX, Milinovich A, Weng W, Bauman JM, Ganguly R, Burguera B, Kattan MW, Zimmerman RS.

Diabet Med. 2019 Jan 17. doi: 10.1111/dme.13900. [Epub ahead of print]

PMID:
30653705
20.

Guidelines for Reporting of Statistics for Clinical Research in Urology.

Assel M, Sjoberg D, Elders A, Wang X, Huo D, Botchway A, Delfino K, Fan Y, Zhao Z, Koyama T, Hollenbeck B, Qin R, Zahnd W, Zabor EC, Kattan MW, Vickers AJ.

J Urol. 2019 Mar;201(3):595-604. doi: 10.1097/JU.0000000000000001. No abstract available.

PMID:
30633111
21.

A comprehensive data level analysis for cancer diagnosis on imbalanced data.

Fotouhi S, Asadi S, Kattan MW.

J Biomed Inform. 2019 Feb;90:103089. doi: 10.1016/j.jbi.2018.12.003. Epub 2019 Jan 3. Review.

22.

Guidelines for Reporting of Statistics for Clinical Research in Urology.

Assel M, Sjoberg D, Elders A, Wang X, Huo D, Botchway A, Delfino K, Fan Y, Zhao Z, Koyama T, Hollenbeck B, Qin R, Zahnd W, Zabor EC, Kattan MW, Vickers AJ.

Eur Urol. 2019 Mar;75(3):358-367. doi: 10.1016/j.eururo.2018.12.014. Epub 2018 Dec 21.

PMID:
30580902
23.

Guidelines for reporting of statistics for clinical research in urology.

Assel M, Sjoberg D, Elders A, Wang X, Huo D, Botchway A, Delfino K, Fan Y, Zhao Z, Koyama T, Hollenbeck B, Qin R, Zahnd W, Zabor EC, Kattan MW, Vickers AJ.

BJU Int. 2019 Mar;123(3):401-410. doi: 10.1111/bju.14640. Epub 2019 Jan 20.

PMID:
30537407
24.

Nomograms to predict naming decline after temporal lobe surgery in adults with epilepsy.

Busch RM, Hogue O, Kattan MW, Hamberger M, Drane DL, Hermann B, Kim M, Ferguson L, Bingaman W, Gonzalez-Martinez J, Najm IM, Jehi L.

Neurology. 2018 Dec 4;91(23):e2144-e2152. doi: 10.1212/WNL.0000000000006629. Epub 2018 Nov 7.

25.

Reasons for Discontinuing Active Surveillance: Assessment of 21 Centres in 12 Countries in the Movember GAP3 Consortium.

Van Hemelrijck M, Ji X, Helleman J, Roobol MJ, van der Linden W, Nieboer D, Bangma CH, Frydenberg M, Rannikko A, Lee LS, Gnanapragasam VJ, Kattan MW; Members of the Movember Foundation's Global Action Plan Prostate Cancer Active Surveillance GAP3 consortium; Members of the Movember Foundation's Global Action Plan Prostate Cancer Active Surveillance GAP3 consortium.

Eur Urol. 2019 Mar;75(3):523-531. doi: 10.1016/j.eururo.2018.10.025. Epub 2018 Oct 29.

PMID:
30385049
26.

Predicting Current Glycated Hemoglobin Values in Adults: Development of an Algorithm From the Electronic Health Record.

Wells BJ, Lenoir KM, Diaz-Garelli JF, Futrell W, Lockerman E, Pantalone KM, Kattan MW.

JMIR Med Inform. 2018 Oct 22;6(4):e10780. doi: 10.2196/10780.

27.

Editorial Comment.

Kattan MW.

J Urol. 2018 Dec;200(6):1377. doi: 10.1016/j.juro.2018.06.103. Epub 2018 Sep 21. No abstract available.

PMID:
30243814
28.

Use of Visual Decision Aids in Physician-Patient Communication: A Pilot Investigation.

Mercer MB, Rose SL, Talerico C, Wells BJ, Manne M, Vakharia N, Jolly S, Milinovich A, Bauman J, Kattan MW.

J Patient Exp. 2018 Sep;5(3):167-176. doi: 10.1177/2374373517746177. Epub 2017 Dec 14.

29.

Prostate-Specific Antigen Trends Predict the Probability of Prostate Cancer in a Very Large U.S. Veterans Affairs Cohort.

Karnes RJ, MacKintosh FR, Morrell CH, Rawson L, Sprenkle PC, Kattan MW, Colicchia M, Neville TB.

Front Oncol. 2018 Aug 6;8:296. doi: 10.3389/fonc.2018.00296. eCollection 2018.

30.

Testing of a Tool for Prostate Cancer Screening Discussions in Primary Care.

Misra-Hebert AD, Hom G, Klein EA, Bauman JM, Gupta N, Ji X, Stephenson AJ, Jones JS, Kattan MW.

Front Oncol. 2018 Jun 28;8:238. doi: 10.3389/fonc.2018.00238. eCollection 2018.

31.

Models for Predicting Recurrence, Complications, and Health Status in Women After Pelvic Organ Prolapse Surgery.

Jelovsek JE, Chagin K, Lukacz ES, Nolen TL, Shepherd JP, Barber MD, Sung V, Brubaker L, Norton PA, Rahn DD, Smith AL, Ballard A, Jeppson P, Meikle SF, Kattan MW; NICHD Pelvic Floor Disorders Network.

Obstet Gynecol. 2018 Aug;132(2):298-309. doi: 10.1097/AOG.0000000000002750.

32.

Association Between Androgen Deprivation Therapy and Patient-reported Depression in Men With Recurrent Prostate Cancer.

Thomas HR, Chen MH, D'Amico AV, Bennett CL, Kattan MW, Sartor O, Stein K, Nguyen PL.

Clin Genitourin Cancer. 2018 Aug;16(4):313-317. doi: 10.1016/j.clgc.2018.05.007. Epub 2018 Jun 1.

PMID:
29866496
33.

Targets without tolerances: improper evaluation of medical personnel.

Butler RS, Johnston D, Kattan MW.

Ann Transl Med. 2018 Apr;6(8):149. doi: 10.21037/atm.2018.03.35.

34.

Prostate Cancer Screening-A New Recommendation for Meaningful Physician-Patient Conversations.

Misra-Hebert AD, Kattan MW.

JAMA Oncol. 2018 Aug 1;4(8):1049-1050. doi: 10.1001/jamaoncol.2018.1492. No abstract available.

PMID:
29801021
35.

A Contemporary Prostate Biopsy Risk Calculator Based on Multiple Heterogeneous Cohorts.

Ankerst DP, Straubinger J, Selig K, Guerrios L, De Hoedt A, Hernandez J, Liss MA, Leach RJ, Freedland SJ, Kattan MW, Nam R, Haese A, Montorsi F, Boorjian SA, Cooperberg MR, Poyet C, Vertosick E, Vickers AJ.

Eur Urol. 2018 Aug;74(2):197-203. doi: 10.1016/j.eururo.2018.05.003. Epub 2018 May 16.

36.

Clinical Inertia in Type 2 Diabetes Management: Evidence From a Large, Real-World Data Set.

Pantalone KM, Misra-Hebert AD, Hobbs TM, Ji X, Kong SX, Milinovich A, Weng W, Bauman J, Ganguly R, Burguera B, Kattan MW, Zimmerman RS.

Diabetes Care. 2018 Jul;41(7):e113-e114. doi: 10.2337/dc18-0116. Epub 2018 Apr 20. No abstract available.

PMID:
29678811
37.

Antidiabetic treatment patterns and specialty care utilization among patients with type 2 diabetes and cardiovascular disease.

Pantalone KM, Misra-Hebert AD, Hobbs TM, Ji X, Kong SX, Milinovich A, Weng W, Bauman J, Ganguly R, Burguera B, Kattan MW, Zimmerman RS.

Cardiovasc Diabetol. 2018 Apr 10;17(1):54. doi: 10.1186/s12933-018-0699-7.

38.

Tutorial: development of an online risk calculator platform.

Ji X, Kattan MW.

Ann Transl Med. 2018 Feb;6(3):46. doi: 10.21037/atm.2017.11.37.

39.

Extracting and utilizing electronic health data from Epic for research.

Milinovich A, Kattan MW.

Ann Transl Med. 2018 Feb;6(3):42. doi: 10.21037/atm.2018.01.13.

40.

External validation of the TIMI risk score for secondary cardiovascular events among patients with recent myocardial infarction.

Williams BA, Chagin KM, Bash LD, Boden WE, Duval S, Fowkes FGR, Mahaffey KW, Patel MD, D'Agostino RB, Peterson ED, Kattan MW, Bhatt DL, Bonaca MP.

Atherosclerosis. 2018 May;272:80-86. doi: 10.1016/j.atherosclerosis.2018.03.026. Epub 2018 Mar 16.

PMID:
29579671
41.

Patient Characteristics Associated With Severe Hypoglycemia in a Type 2 Diabetes Cohort in a Large, Integrated Health Care System From 2006 to 2015.

Misra-Hebert AD, Pantalone KM, Ji X, Milinovich A, Dey T, Chagin KM, Bauman JM, Kattan MW, Zimmerman RS.

Diabetes Care. 2018 Jun;41(6):1164-1171. doi: 10.2337/dc17-1834. Epub 2018 Mar 16.

PMID:
29549082
42.

Ten-Year Outcomes and Risk Factors After Anterior Cruciate Ligament Reconstruction: A MOON Longitudinal Prospective Cohort Study.

MOON Knee Group, Spindler KP, Huston LJ, Chagin KM, Kattan MW, Reinke EK, Amendola A, Andrish JT, Brophy RH, Cox CL, Dunn WR, Flanigan DC, Jones MH, Kaeding CC, Magnussen RA, Marx RG, Matava MJ, McCarty EC, Parker RD, Pedroza AD, Vidal AF, Wolcott ML, Wolf BR, Wright RW.

Am J Sports Med. 2018 Mar;46(4):815-825. doi: 10.1177/0363546517749850.

43.

The c-index is not proper for the evaluation of $t$-year predicted risks.

Blanche P, Kattan MW, Gerds TA.

Biostatistics. 2019 Apr 1;20(2):347-357. doi: 10.1093/biostatistics/kxy006.

PMID:
29462286
44.

Prostate cancer: Numeracy and understanding of risk reduction of PSA screening.

Subramanian V, Kattan MW.

Nat Rev Urol. 2018 Apr;15(4):208-209. doi: 10.1038/nrurol.2018.21. Epub 2018 Feb 20. Review. No abstract available.

PMID:
29460924
45.

Validation of nomograms for overall survival, cancer-specific survival, and recurrence in carcinoma of the major salivary glands.

Hay A, Migliacci J, Zanoni DK, Patel S, Yu C, Kattan MW, Ganly I.

Head Neck. 2018 May;40(5):1008-1015. doi: 10.1002/hed.25079. Epub 2018 Feb 1.

46.

Next-generation prostate cancer risk calculator for primary care physicians.

Nam RK, Satkunavisam R, Chin JL, Izawa J, Trachtenberg J, Rendon R, Bell D, Singal R, Sherman C, Sugar L, Chagin K, Kattan MW.

Can Urol Assoc J. 2018 Feb;12(2):E64-E70. doi: 10.5489/cuaj.4696. Epub 2017 Dec 1.

47.

Predicting the cure rate of breast cancer using a new regression model with four regression structures.

Ramires TG, Cordeiro GM, Kattan MW, Hens N, Ortega EM.

Stat Methods Med Res. 2018 Nov;27(11):3207-3223. doi: 10.1177/0962280217695344. Epub 2017 Feb 23.

PMID:
29298615
48.

Larissa Heart Failure Risk Score: a proposed simple score for risk stratification in chronic heart failure.

Xanthopoulos A, Tryposkiadis K, Giamouzis G, Konstantinou D, Giannakoulas G, Karvounis H, Kattan MW, Skoularigis J, Parissis J, Starling RC, Triposkiadis F.

Eur J Heart Fail. 2018 Mar;20(3):614-616. doi: 10.1002/ejhf.1132. Epub 2017 Dec 22. No abstract available.

49.

Nomogram for survival analysis in the presence of competing risks.

Zhang Z, Geskus RB, Kattan MW, Zhang H, Liu T.

Ann Transl Med. 2017 Oct;5(20):403. doi: 10.21037/atm.2017.07.27.

50.

Prevalence and recognition of obesity and its associated comorbidities: cross-sectional analysis of electronic health record data from a large US integrated health system.

Pantalone KM, Hobbs TM, Chagin KM, Kong SX, Wells BJ, Kattan MW, Bouchard J, Sakurada B, Milinovich A, Weng W, Bauman J, Misra-Hebert AD, Zimmerman RS, Burguera B.

BMJ Open. 2017 Nov 16;7(11):e017583. doi: 10.1136/bmjopen-2017-017583.

Supplemental Content

Loading ...
Support Center